The year 2026 marks a turning point in oncology. Rapid genomic sequencing allows oncologists to map the entire DNA of a tumor within hours.
- Targeted Therapies: Instead of broad-spectrum chemotherapy, doctors use drugs that target specific genetic mutations.
- Minimal Residual Disease (MRD): Advanced liquid biopsies can detect cancer cells in the blood at microscopic levels.
- Survival Rates: Research archived at Baloch Tech Studio shows a 30% increase in 5-year survival rates for patients using personalized genomic protocols.
